G-BOND
K041471 · GC America, Inc. · KLE · Jun 29, 2004 · Dental
Device Facts
| Record ID | K041471 |
| Device Name | G-BOND |
| Applicant | GC America, Inc. |
| Product Code | KLE · Dental |
| Decision Date | Jun 29, 2004 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3200 |
| Device Class | Class 2 |
Intended Use
This product is a light-cured dentin bonding agent to effective bonding to resin composite provide restorative materials.
Device Story
G-BOND is a light-cured resin tooth bonding agent; used by dental professionals in clinical settings to adhere resin composite restorative materials to dentin. Device applied to tooth surface; light-cured to initiate polymerization; creates bond between tooth structure and restorative material. Facilitates restorative dental procedures; improves retention of composite restorations.
Clinical Evidence
Bench testing only.
Technological Characteristics
Light-cured resin bonding agent. Chemical composition typical of dental adhesive systems. Formulated for application to dentin to facilitate bonding with resin-based restorative materials. Polymerization initiated via external light source.
Indications for Use
Indicated for use as a light-cured dentin bonding agent to facilitate the bonding of resin composite restorative materials to tooth structure.
Regulatory Classification
Identification
A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling.
Related Devices
- K082768 — G-BOND PLUS · GC America, Inc. · Oct 21, 2008
- K180803 — BeautiBond Universal · Shofu Dental Corporation · Sep 26, 2018
- K051006 — IBOND NEXT GENERATION · Heraeus Kulzer,GmbH · Jun 7, 2005
- K043562 — BC PLUS · Vericom Co., Ltd. · Jan 3, 2005
- K012432 — MODIFICATION TO CLEARFIL PHOTO BOND · Kuraray Medical, Inc. · Sep 4, 2001
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wings. The eagle is enclosed within a circle, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper half of the circle. The logo is black and white.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 2 9 2004
Ms. Terry L. Joritz Director, Regulatory Affairs & Quality Control GC America, Incorporated 3737 West 127th Street Alsip, Illinois 60803
Re: K041471
Trade/Device Name: G-BOND Regulation Number: 872.3200 Regulation Name: Resin Tooth Bonding Agent Regulatory Class: II Product Code: KLE Dated: June 1, 2004 Received: June 9, 2004
Dear Ms. Joritz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Page 2 - Ms. Joritz
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Qurs
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
510(k) Number (if known): 燦 ○∀ | Ч ך |
G-BOND Device Name:
Indications for Use:
This product is a light-cured dentin bonding agent to effective bonding to resin composite provide restorative materials.
Prescription Use (21 CFR Part 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR Part 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Runore
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devic
510(k) Number: _
Page 1 of 1